Price: $82.25
· 1 day: -0.41% · 5 days: -1.26% · 1 month: -3.72% · YTD: +9.03%
As of 2026-11-03 21:00 UTC.
52-week range: $72.11 – $88.62 (currently at 61% of the range).
VXUS is in a downtrend, momentum soft. $83.46 is the level overhead; $81.84 the first support below.
5 of 6 technical checks lean bearish.
| Trend | Downtrend · below 50-day & below 200-day |
|---|---|
| Momentum | RSI 39.19 · neutral · MACD bearish |
| Trend strength | ADX 22.7 · developing |
| Location | -3.6% vs 50-day MA |
| 52-week range | -7% from high · +14% from low |
| Volatility | ATR 0.89 · ~1.1%/day |
| Level | Type | Distance |
|---|---|---|
| $83.46 (resistance) | sma 200 | 1.47% |
| $84.19 (resistance) | swing zone | 2.36% |
| $85.36 (resistance) | sma 50 | 3.78% |
| $81.84 (support) | swing zone | -0.5% |
| $80.0 (support) | round | -2.74% |
| $76.18 (support) | swing zone | -7.38% |
| RSI (14) | 39.19 | MACD | -0.7538 |
|---|---|---|---|
| ADX (14) | 22.7 | ATR (14) | 0.89 |
| 50-day average | $85.36 | 200-day average | $83.46 |
Report of 2026-11-01.
Vanguard Total International Stock Index Fund ETF Shares (VXUS) closed at $82.37 on October 30, 2026, down 1.5% on the day and 0.2% over five sessions, as the fund slipped below its 200-day average and the weekly trend turned down. The balance of evidence for the next 2–6 weeks is now bearish with medium conviction, a shift from the neutral, low-conviction reading of late October. The fund trails the S&P 500 by 2.2% over 50 days, and a daily close below $81.84 would open the path to $76.18 with a reward-to-risk of 3.1.
The move in VXUS is not about any single holding but the broad international equity complex losing momentum. The fund, which tracks the FTSE Global All Cap ex US Index and holds more than 8,500 stocks across developed and emerging markets, has fallen 4.1% from its October 5 peak of $85.85. The 1.5% drop on October 30 came alongside a 1.8% decline in the S&P 500, so the market was the driver, not stock-specific news. Over five days, VXUS fell 0.2% while SPY fell 0.6%, meaning the fund actually outperformed the broad market slightly in that window, but the longer-term picture is weaker: VXUS is down 3.0% over one month versus SPY's 0.9% decline, and down 4.9% relative to SPY over 200 days.
The news flow around VXUS is mostly bullish commentary, not bearish catalysts. Morningstar recently called VXUS one of the best international-stock funds, citing low fees and broad diversification. A separate Morningstar piece highlighted three undervalued international stocks, including AstraZeneca with a fair value estimate of $184 per ADR. But the price action tells a different story: the fund is below its 50-day average of $85.56 and its 200-day average of $83.42, and the relative strength index at 34.4 is approaching oversold territory. The bullish case rests on valuation and diversification, but the market is not rewarding that thesis right now.
The debate is between those who see VXUS as a cheap, diversified way to own international equities and those who see the trend as broken. The bullish camp points to the fund's low fees and the fact that it holds thousands of companies at what appear to be reasonable valuations. The bearish camp notes that the fund has been lagging the S&P 500 for months, and that the 50-day and 200-day averages are both above the current price, a classic downtrend signal. The fund's year-to-date gain of 9.2% trails SPY's 10.8%, and the gap has widened recently. There is no analyst consensus or price target for the ETF itself, so the valuation debate is about the underlying holdings, not the fund's own metrics.
The long-term trend has turned down. VXUS is below its 40-week average, and the daily trend runs with the weekly downtrend. The fund is in the early phase of a downtrend, having broken below its 200-day average of $83.42, where sellers have shown up on rallies. The thesis that international stocks would outperform is weakened but not broken — the fund is still up 14.1% from its 52-week low of $72.19, and the 6-month return is only slightly negative at -0.8%. But the momentum has clearly shifted, and the fund is now in a phase where rallies are being sold.
For the next 2–6 weeks, the balance of evidence leans negative. The conviction is medium, with 2 of 4 points supporting the bearish case: the daily trend aligns with the weekly downtrend, and the fund lags the S&P 500 by 2.2% over 50 days. The strongest case against the bearish reading is that the fund is approaching oversold territory — the RSI at 34.4 suggests a bounce could come at any time, and the 5-day performance actually shows VXUS outperforming SPY slightly. But these are short-term signals against a backdrop of lower highs and lower lows. The fund has not closed below the $81.84 swing zone yet, and a bounce from that level would not be surprising, but the trend is down until proven otherwise.
The structure holds below $83.42, the 200-day average. That is where sellers have shown up on rallies, and the fund closed at $82.37, below that level. The trend would end on a weekly close above $84.19, the swing zone that has capped rallies. Above that, the 50-day average at $85.56 and the swing zone at $86.35 are the next resistance levels. On the downside, the first support is the swing zone at $81.84, followed by the round number at $80.00, then the swing zones at $76.18 and $74.38, and finally the 52-week low at $72.19.
The breakout level is a daily close below $81.84. From there, the math gives a target of $76.18 with a reward-to-risk of 3.1, and a secondary target of $74.38 with a reward-to-risk of 4.1. The stop would be at $83.64, based on the 200-day average of $83.42 plus a quarter of the average true range. This meets the 3-to-1 threshold, making the downside breakout worth the risk. If the fund instead closes above $84.19 on a weekly basis, the bearish structure would be invalidated, and the picture would shift back to neutral or positive.
A weekly close above $84.19, the swing zone, would change the picture from bearish to neutral or positive. That would signal that buyers have stepped in and the downtrend is no longer intact. The non-price factor that would change the picture is a broad market rally that lifts international equities along with it — if the S&P 500 breaks to new highs and VXUS follows, the relative weakness could reverse. But until that happens, the evidence points lower.
Interactive VXUS chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs